During the election campaign, Prime Minister Scott Morrison and Health Minister Greg Hunt have repeatedly spruiked the Government’s listing of medicines on the Pharmaceutical Benefits Scheme... Read more
So here’s a question, or two. For months, we’ve been hearing many different experts and health organisations warning about the risks to health from the Trans-Pacific Partnership (TPP) trade... Read more
A new campaign, to be formally launched at the Royal Australian College of General Practitioners conference in Adelaide on Saturday, will urge doctors to stop seeing pharmaceutical company r... Read more
Note: A response from the TGA was added on 28 March – see bottom of post. Questions are again being raised about the effectiveness of the Therapeutic Goods Administration as a regulato... Read more
There is an international trend towards nurses having a greater role in prescribing of medicines, And The evolution of primary health care organisations in Australia. These issues are explor... Read more
Are we doing enough to identify and address current and potential problems with the supply of essential medicines? This is one of many questions raised by a thought-provoking article in the... Read more
This article was first published at The Conversation. Philip Soos writes: Over the last couple of decades, the pharmaceutical industry has come under attack for its perceived shortcomings am... Read more
Glenn Salkeld, professor of health economics at the University of Sydney, provides some useful context to the debate about listing of new medicines on the Pharmaceutical Benefits Scheme (PBS... Read more
The Federal Government has drawn widespread criticism for its decision to defer PBS listing of medicines approved by the Pharmaceutical Benefits Advisory Committee But there are other ways i... Read more
Carol Bennett, CEO of the Consumers Health Forum, writes: I would describe last night’s health Budget lock-up as a very quiet gathering which is probably a good indication of general approva... Read more
